TB006 is a groundbreaking experimental drug that slows the progression of Alzheimer’s disease.
It works by targeting one of the causes of the condition, making it highly effective at improving—and even reversing—the symptoms of dementia.
But how much does TB006 cost?
This article breaks down the costs of TB006 and explains whether you can qualify for access to the drug at Universal Neurological Care.
The answer to “How much does TB006 cost?” depends on how you access treatment.
At this stage, TB006 is experimental and still undergoing clinical trials. If you partake in a clinical trial, we have good news: access to the medication is free!
However, not everyone will qualify for these trials or wish to participate in a clinical study.
If you don’t meet the study eligibility criteria, the only other way to get TB006 is through the Expanded Access Program (EAP). We’re going to be honest: getting TB006 through the EAP is expensive.
If you decide to partake in the program, you will need to cover the following costs:
Although the FDA approves manufacturing costs, your clinic decides physician fees and assessment charges.
Please speak with your physician to find out more, or contact our team for a breakdown of the TB006 cost at Universal Neurological Care.
Whether the TB006 Expanded Access Program is worth the cost depends on who you ask and your unique financial situation. Many believe the following benefits of TB006 justify the expense:
Although TB006 is expensive, its price is more easily justified when considering the cost of its competitors, Lequembi and Aduhelm.
These are the only two FDA-approved drugs that, like TB006, target the causes of Alzheimer’s disease.
Leqembi costs $26,500 per year, which is out of pocket for many Alzheimer’s patients. According to the Institute for Clinical and Economic Review (a group that helps determine a fair price for new medication), this is overpriced. They suggested an appropriate cost of $8,500 to $20,600 annually.
However, it’s more affordable than Aduhelm. According to NBC News, this drug was approved in 2021 and was priced at $56,000 per year.
With almost 7 million Americans living with Alzheimer’s disease, this is disappointing news for many patients and their loved ones.
The only way to get TB006 for free is to participate in a clinical trial. This grants you access to free medication throughout the study, but you’ll have to pay if you want to continue the drug after the study has been completed.
Another way to lower TB006 costs is by claiming the fees through your health insurance policy. Universal Neurological Care accepts most major insurance policies, including United Healthcare, Cigna, Tricare, Humana, and Aetna.
Please get in touch with your provider to see whether you can claim the cost of TB006 for Alzheimer’s through your health insurance company.
Q: How much will Leqembi cost?
A: Leqembi, one of the main competitors of TB006, costs $26,500 per year. This is over the recommended price given in the Institute of Clinical and Economic Review report.
Q: What is the cost of Alzheimer’s drugs?
A: Alzheimer’s drugs are expensive, costing up to $56,000 per year. However, you can get free access to the new experimental drug TB006 by partaking in a clinical trial.
Q: How much does TB006 cost?
A: If paying for TB006 EAP, you must cover the cost of producing the drug, physician fees, and all laboratory tests and analyses. Contact your clinic for a full breakdown of charges.
The Expanded Access Program for TB006 isn’t available for everyone.
While there is no limit on the number of Alzheimer’s patients we can treat at Universal Neurological Care, we can only administer TB006 if you meet the following key eligibility criteria:
If you meet these criteria, contact our team. We can discuss the medication, physician fees, and laboratory testing costs for the EAP program and help you start your treatment journey.
